DIGESTIVE DISEASE WEEK 2008: Schedule of Accepted Abstracts
At DDW 2008, 17 scientific abstracts will be presented that relate to clinical trials conducted with the HALO ablation systems.
These presentations further add to a growing body of evidence and experience for this intervention in treating a patient with
Barrett's esophagus.
The following is a schedule of the abstracts to be presented in oral or poster format. For more information on the abstracts
and DDW sessions please go to www.DDW.org.
For more information on the HALO Technology at DDW 2008 use the BÂRRX Medical contact form
DDW and Medical Societies' Podium Presentations at the San Diego Convention Center
SSAT Presidential: Plenary A (Plenary Session I). Monday, May 19, 8:15 a.m., Room #25
ID # 215:
Stepwise circumferential and focal radiofrequency ablation of Barrett’s esophagus with
high-grade dysplasia or intramucosal cancer (J. J. Bergman, et al)
AGA Institute: Clinical Science Plenary, Monday, May 19, 9:00 a.m., Room# 20BCD
ID # 213: A Randomized, Multicenter, Sham-Controlled Trial of Radiofrequency
Ablation (RFA) for Subjects with Barrett’s Esophagus (BE) Containing Dysplasia: Interim
Results of the AIM Dysplasia Trial (N. J. Shaheen, et al)
ID# 761: The Utility of Endoscopic Ultrasound (EUS) In Patients With Barrett's
Esophagus (BE) and High Grade Dysplasia (HGD): Analysis of the AIM Dysplasia Trial Experience (R. Muthusamy, et al)
DDW and Medical Societies' Poster Sessions at the San Diego Convention Center – Sails Pavilion Posters will be on display from 8:00 a.m. to 5:00 p.m. with an author present at the poster location between 12:00 p.m. and 2:00 p.m.
ASGE: Endoscopic Technology, Sunday, May 18th
ID # S1441: Stepwise circumferential and focal radiofrequency energy ablation of Barrett's esophagus
with early neoplasia: first European multi-centre trial (R.E. Pouw, et al)
ID # S1475: Complications following circumferential radiofrequency energy ablation of Barrett's
esophagus containing early neoplasia (R. E. Pouw, et al.)
ASGE: Esophagus, Monday, May 19th
ID # M1295: Clinical and endoscopic characteristics of a large cohort of Barrett’s
esophagus (BE) patients with low and high-grade dysplasia (P. Sharma, et al)
ID # M1305: Subsquamous intestinal metaplasia is a common finding in ablation-naïve patients with
dysplastic Barrett’s esophagus, and significantly decreases in prevalence after radiofrequency ablation
(N. J. Shaheen, et al)
ID # M1321: Interim Analysis of Barrett's esophagus eradication by radiofrequency ablation
(J.C. Hernandez, et al)
ID # M1323: A promising new combined treatment modality for Barrett’s esophagus containing
early neoplasia: endoscopic resection followed by step-wise circumferential and focal radiofrequency
energy ablation (R. E. Pouw, et al)
ID #M1326: Predictors and quantitative assessment of incomplete response after radiofrequency
ablation for dysplastic Barrett’s esophagus: Analysis of randomized sham-controlled clinical trial
(The AIM Dysplasia Trial) (C. J. Lightdale, et al)
AGA Institute: Barrett’s Esophagus Diagnosis and Management, Monday, May 19th
ID # M1933: Biopsy yield of dysplastic Barrett’s esophagus based on location within the Barrett’s
segment (E. S. Dellon, et al)
ID # M1935: Stepwise circumferential and focal radiofrequency ablation of Barrett’s esophagus
preserves esophageal diameter, compliance and motility (H. Beaumont, et al)
ID # M1942: Comparison of Catheter-Based Radiofrequency Ablation and Photodynamic Therapy for
Barrett’s Esophagus (J. M. Bumgarner, et al)
AGA Institute: Barrett’s Esophagus Diagnosis and Management, Monday, May 19th
ID # M1944: The molecular pathology of radiofrequency mucosal ablation of Barrett's esophagus (D. Finkelstein, et al)
AGA Institute GERD, Barrett's Esophagus, and Esophageal Cancer: Monday, May 19
ID #M1030: Impact of Barrett's esophagus containing dysplasia on patient quality of
life: Interim results of a randomized, sham-controlled trial of radiofrequency ablation (AIM Dysplasia Trial) (N. J. Shaheen, et al)
SSAT: Session I Clinical/Colon Rectal , Monday, May 19th
ID #M1510: Dosimetric Evaluation of Endoscopic Radiofrequency Ablation in the Human
Colonic Epithelium in a Treat and Resect Trial (J. A. Trunzo, et al)
AGA Institute: Endoscopic Detection of Premalignant Lesions of the UGI Tract, Wednesday, May 21st
ID #W1876: Are biopsies after ablation for dysplastic Barrett's esophagus of adequate depth to detect glandular mucosa beneath the neosquamous epithelium? – Comparative histopathological outcomes from a randomized, sham-controlled trial (AIM Dysplasia Trial) (N. J. Shaheen, et al)
